-
Bristol-Myers Squibb Will Acquire Celgene In Blockbuster $74B Deal
STAT | The transaction between biopharma giants joins two of the largest companies in oncology, both of which have been facing setbacks.
Jan 3, 2019
-
Top 10 Stories Of 2018: Data Science, Five Use Cases For AI And Machine Learning, And More
Bio-IT World | As we head into 2019, we at Bio-IT World would like to take a moment and reflect on the groundbreaking achievements from this past year. In that spirit, here are the top 10 stories of 2018.
Jan 2, 2019
-
Poll Americans Support Gene-Editing Embryos To Prevent Diseases
STAT | Most Americans say it would be OK to use gene-editing technology to create babies protected against a variety of diseases - but a new poll shows they'd draw the line at changing DNA so children are born smarter, faster or taller.
Dec 28, 2018
-
AI In The Clinic: What AI Will Look Like For Healthcare
Bio-IT World | Artificial Intelligence will have as transformational an impact as the internet did, predicts Jay Bellissimo, managing partner at IBM services. Every company needs an AI strategy, he says, and it is not a problem only for IT. Data creates insight, and insight creates knowledge. Mining the 80% of the data that’s not searchable via the internet is your company’s data advantage.
Dec 21, 2018
-
PetaGene Announces $2.1M To Further Genomic Compression
Bio-IT World News Brief PetaGene, a two-time winner of Bio-IT World’s Best of Show award for product excellence, has announced $2.1 million in new funding.
Dec 20, 2018
-
Biogen, DDN, Qlucore, And More: News From December 2018
Bio-IT World | November featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Biogen, DDN, Qlucore, and more.
Dec 19, 2018
-
Oak Ridge Tackles Opioids With Assistance From World’s Fastest Supercomputer
Bio-IT World | The US Department of Energy’s Oak Ridge National Laboratory is tackling the opioid crisis by using the world’s fastest supercomputer. With the help of IBM’s recently launched Summit supercomputer, the Oak Ridge team was able to analyze 85 million genetic markers and understand complex, epistatic genetic architectures responsible for challenging traits in phenotype.
Dec 14, 2018
-
Allen Institute Announces New Division Dedicated To Studying Human Immune System
Bio-IT World | The Allen Institute announced a new division, the Allen Institute for Immunology, which will be dedicated to studying the human immune system.
Dec 13, 2018
-
Pharma’s AI Future
Bio-IT World | The recent AI World Conference & Expo made one thing clear: now is the time for pharma to embrace AI and start realizing some of the benefits other industries are enjoying.
Dec 12, 2018
-
Rehm Replaces Haussler As GA4GH Vice Chair, Other Changes
Bio-IT World Brief GA4GH announced several changes in leadership. GA4GH Vice Chair David Haussler, Scientific Director of the University of California Santa Cruz Genomics Institute, will be succeeded by Heidi Rehm,an institute member at the Broad Institute of MIT and Harvard and chief genomics officer at Massachusetts General Hospital.
Dec 10, 2018
-
10x Genomics Acquires Spatial Genomics Company
Bio-IT World Brief 10x Genomics has acquired Stockholm-based Spatial Transcriptomics, a pioneer in the emerging field of spatial genomics. The new field enables researchers to not only see what is in a cell but how cells are organized in relation to one another, offering up invaluable insight into understanding disease.
Dec 10, 2018
-
A Mature Capital Structure Positions Bio-IT Startups For Success
Bio-IT World Contributed Commentary | By establishing a mature capital structure reflecting a healthy balance of both equity and debt, early-stage bio-IT companies can project long-term strength and vision that helps to favorably position them with their stakeholders.
Dec 6, 2018
-
GSK Bags Tesaro For $5B As It Leaps Back Into Commercial Oncology, Beefs Up Cancer Drug Pipeline
Endpoints News | GlaxoSmithKline has struck a deal to buy Tesaro in a $5.1 billion deal that will vault the pharma giant into the commercial oncology market as it stakes out a big new role for itself in the booming cancer field.
Dec 5, 2018
-
OmniTier Debuts CompStor Novos Platform For De Novo Assembly-Based Variant Calling
Bio-IT World News Brief | OmniTier has debuted the CompStor Novos platform for de novo assembly-based variant calling in whole genome sequencing applications.
Dec 5, 2018
-
Despite CRISPR Baby Controversy, Harvard University Will Begin Gene-Editing Sperm
MIT Technology Review | Even as a furious debate broke out in China over gene-edited babies, some scientists in the US are also hoping to improve tomorrow's children.
Nov 30, 2018
-
Facing Backlash, Chinese Scientist Defends Gene-Editing Research On Babies
NPR.org | He Jiankui, who shocked the world by asserting he had genetically edited twin girls, faced growing criticism from other researchers as he spoke at a scientific conference in Hong Kong.
Nov 28, 2018
-
UberCloud, The Wellcome Sanger Institute, Panasas, And More: News From November 2018
Bio-IT World | November featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including UberCloud, the Wellcome Sanger Institute, Panasas, and more.
Nov 28, 2018
-
Claim Of CRISPR'ed Baby Girls Stuns Genome Editing Summit
STAT | A researcher's claim that he used genome editing to alter DNA of human embryos, resulting in the birth a few weeks ago of twin girls, stunned scientists.
Nov 26, 2018
-
Single-Cell Sequencing Is Opening Up New Avenues For Potential Treatments
STAT | By quickly analyzing thousands - even millions - of cells, it's now possible to visualize the specific cellular culprits for any given disease.
Nov 21, 2018
-
Researchers Assemble Pan-Genome From 910 Humans Of African Descent Using Deep Sequencing
Bio-IT World | Researchers from Johns Hopkins University and other institutions recently conducted a study that used a deeply sequenced dataset of over 900 individuals of African descent to construct a set of DNA sequences that is missing from the current reference human genome.
Nov 20, 2018